Frequently Asked Questions
The market is segmented based on , By Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others), End User (Pharmaceutical companies, Healthcare Service Providers, Research Organizations and Academic Research Institutes), Function (Vaccines, Enzymatic and Regulatory, Protein Diagnostics) – Industry Trends and Forecast to 2030.
.
The Global Protein Therapeutics Market size was valued at USD 115.17 USD Billion in 2022.
The Global Protein Therapeutics Market is projected to grow at a CAGR of 6.68% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, Amgen, Baxter, Eli Lilly, F. Hoffmann, La Roche, Johnson & Johnson, Merck, Novo Nordisk, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceutical Industries, Kyowa Kirin, AbbVie, Generex Biotechnology, CSL, Biogen, Genentech, Bristol Myers Squibb.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa.
